核医学显像在乳腺癌诊疗中的作用

汪秀玲; 侯先存; 徐凯

核医学显像在乳腺癌诊疗中的作用

汪秀玲 , 侯先存 , 徐凯

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 4: (222-224)

引用本文:

Citation:

核医学显像在乳腺癌诊疗中的作用

221002 徐州, 徐州医学院附属医院影像科

通讯作者: 汪秀玲, xuzhouwangxl@hotmail.com ;

中图分类号: R817.4

The effection of nuclear medicine in the diagnosis and treat of breast cancer

Department of Imaging, The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China

Corresponding author: WANG Xiu-ling, xuzhouwangxl@hotmail.com ;

CLC number: R817.4

摘要: 乳腺癌发病率逐年增高,诊疗技术也不断发展,核医学检查在乳腺癌诊疗中起到重要作用,如用于乳腺癌诊断的乳腺闪烁显像,放射性核素对前哨淋巴结的检出,检查骨转移的骨闪烁显像及PET在乳腺癌原发灶诊断的应用等。
- 乳腺肿瘤 /
- 放射性核素显像
Abstract: The incidence of breast cancer has been increasing recently. Nuclear medicine plays an important role in the diagnosis and treat of breast cancer:breast scintigraphy in the diagnosis of breast cancer, the detection of sentinel lymph node using radioisotope, skeleton scintigraphy in the diagnosis of osseous metastasis, the application of PET in breast cancer, for instance.
- Breast neoplasms /
- Radionuclide imaging
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Koizumi M.Nuclear medicine in breast cancer.Jpn J Diagn Imaging,2005,25(10):1257-1263.
[2]	Bagni B,Franceschetto A,Casolo A,et al.Seintimammography with ^99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.Eur J Nuel Med Mol Imaging,2003,30(11):1383-1388.
[3]	Aursvold JN,Alazraki NP.Updata on detection of sentinel lymph nodes in patients with breast cancer.Semin Nucl Med,2005,35(1):116-128.
[4]	Koizumi M,Nomura E,Yamada Y,et al.Radioguided sentinel node detection in breast cancer patients:comparion of ^99mTc phytate and ^99mTc rheninum colloid efficary.Nucl Med Commun,2004,25(9):1031-1034.
[5]	Veronesi U,Paganellic G,Viale G,et al.A randomized comparion of sentinel-node biopsy with routine axillary dissection in breast cancer.N Engl J Med,2003,349(6):546-553.
[6]	Kimiihi Uno,Jin Wu,Weijeyko,et al.Diagnostic imaging using FDG-PET in breast cancer.Jpn J Diagn Imaging,2005,25(9):1120-1128.
[7]	Avri N,Rose CA,Schelling M,et al.Breast imaging with position emission tomography and[fluoro-18]-fluorodeoxyglucose:use and limitation.J Clin Oncol,2000,18(12):3495-3502.
[8]	Eubank WB,Mankoff DA.Erovling role of position emission tomography in breast cancer imaging.Semin Nucl Med,2005,35(1):84-99.
[9]	Wahl RL,Siegel BA,Coleman RE,et al.Prospective multicenter study of axillary nodel staging with FDG position emission tomography in breast cancer.J Clin Oncol,2004,22(3):277-285.
[10]	Suarez M,Petez-castejon MJ,Jimenez A,et al.Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.Q J Nucl Med,2002,46(1):113-121.
[11]	Eubank WB,Mankoff DA,Bhattacharya M,et al.Impact of[F-18]-fluorodeoxyglucose PET on defining the extent of disease and mamagement of patients with recurrent or metastatic breast cancer.AJR,2004,183(2):479-486.

[1]	关晏星 . 乳腺癌核素分子显像的临床研究进展. 国际放射医学核医学杂志, 2006, 30(4): 225-228,231.
[2]	姚兰琳 , 吴华 , 郭崴 . 乳腺癌核素靶向诊疗一体化的研究进展. 国际放射医学核医学杂志, 2020, 44(11): 728-736. doi: 10.3760/cma.j.cn121381-201909026-00081
[3]	马乐 , 张万春 , 李晓敏 . 乳腺癌前哨淋巴结核素显像新进展. 国际放射医学核医学杂志, 2016, 40(2): 145-148, 158. doi: 10.3760/cma.j.issn.1673-4114.2016.02.012
[4]	郭睿 , 晋建华 . ^99mTc-depreotide生长抑素受体显像的临床应用研究. 国际放射医学核医学杂志, 2007, 31(3): 154-157.
[5]	王佳琼 , 王自正 , 姚薇萱 , 王峰 . 乳腺肿瘤生长抑素受体表达与生长抑素受体显像. 国际放射医学核医学杂志, 2006, 30(1): 17-21.
[6]	马海彦 , 谢光友 , 张莎莎 , 郑兴菊 , 刘江勇 , 王荣品 . 乳腺专用γ显像的肿瘤/正常组织比值与乳腺浸润性导管癌病理学的对比研究. 国际放射医学核医学杂志, 2020, 44(7): 422-428. doi: 10.3760/cma.j.cn121381-201906010-00058
[7]	刘超 , 邓智勇 , 刘鹏杰 , 贾莉 . ⁸⁹SrCL₂与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析. 国际放射医学核医学杂志, 2014, 38(5): 300-303. doi: 10.3760/cma.j.issn.1673-4114.2014.05.006
[8]	刘晓梅 , 魏玲格 , 张芳 . 以血管生成为分子靶点的放射性核素显像分子探针在肿瘤个体化用药中的应用. 国际放射医学核医学杂志, 2017, 41(5): 363-369. doi: 10.3760/cma.j.issn.1673-4114.2017.05.011
[9]	孟召伟 , 董峰 , 谭建 . 乳腺癌的雌激素受体显像. 国际放射医学核医学杂志, 2007, 31(3): 157-159.
[10]	胡鸿 , 唐刚华 , 聂大红 . 乳腺癌分子显像研究进展. 国际放射医学核医学杂志, 2015, 39(1): 91-95. doi: 10.3760/cma.j.issn.1673-4114.2015.01.019